Skip to main content

Table 3 Levels of lipids and CRP among different APOE ε genotypes carriers

From: Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population

APOE ε genotypes

T-cholesterol (mg/dL)

Beta (95 % CI)

P valuea

LDL-C (mg/dL)

Beta (95 % CI)

P valuea

Triglyceride (mg/dL)

Beta (95 % CI)

P valuea

HDL-C (mg/dL)

Beta (95 % CI)

P valuea

CRP (mg/L)

Beta (95 % CI)

P valuea

ε2 (n = 81)

181.7 ± 36.2

0.03 (0.01–0.04)

4.24 × 10−5

96.5 ± 27.6

0.05 (0.03–0.07)

1.94 × 10−7

138.4 ± 114.1

0.03 (−0.003–0.06)

0.054

57.3 ± 15.2

−0.02 (−0.03 to −0.002)

0.008

1.09 ± 1.70

−0.08 (−0.14 to −0.01)

0.018

ε3 (n = 399)

200.2 ± 35.1

118.1 ± 32.1

138.3 ± 121.1

55.5 ± 14.7

1.13 ± 1.33

ε4 (n = 96)

205.0 ± 36.9

122.3 ± 32.0

165.5 ± 119.7

51.7 ± 11.8

0.88 ± 1.33

ε2 (n = 81)

181.7 ± 36.2

0.05 (0.03–0.06)

6.65 × 10−6

96.5 ± 27.6

0.09 (0.06–0.12)

5.12 × 10−9

138.4 ± 114.1

0.01 (−0.05–0.06)

0.779

57.3 ± 15.2

−0.02 (−0.04–0.01)

0.172

1.09 ± 1.70

0.02 (−0.09–0.12)

0.782

Non-ε2 (n = 495)

201.1 ± 35.5

118.9 ± 32.1

143.6 ± 121.2

54.8 ± 14.2

1.08 ± 1.33

ε4 (n = 96)

205.0 ± 36.9

0.02 (−0.002–0.03)

0.068

122.3 ± 32.0

0.03 (0.004–0.06)

0.031

165.5 ± 119.7

0.06 (0.01–0.11)

0.018

51.7 ± 11.8

−0.02 (−0.04 to −0.001)

0.020

0.88 ± 1.33

−0.19 (−0.28 to −0.09)

2.12 × 10−4

Non-ε4 (n = 480)

197.1 ± 35.9

114.5 ± 32.4

138.3 ± 119.9

55.8 ± 14.7

1.12 ± 1.40

  1. ε2 (ε2ε2 and ε2ε3); ε3 (ε3ε3); ε4 (ε3ε4 and ε4ε4)
  2. aThe multiple linear regressions were adjusted for age, sex, BMI, current smoking status, and anti-hypertensive and anti-diabetic treatments